S&P 500
(0.87%) 5 010.60 points
Dow Jones
(0.67%) 38 240 points
Nasdaq
(1.11%) 15 451 points
Oil
(-1.20%) $82.14
Gas
(0.28%) $1.796
Gold
(-0.07%) $2 344.80
Silver
(0.06%) $27.26
Platinum
(-0.06%) $930.70
USD/EUR
(0.07%) $0.939
USD/NOK
(-0.24%) $10.98
USD/GBP
(0.16%) $0.810
USD/RUB
(0.02%) $93.03

Realtime updates for AxoGen Inc [AXGN]

Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
BUY
100.00%
return 6.02%
SELL
60.00%
return 3.91%
Last Updated22 Apr 2024 @ 16:00

5.54% $ 6.86

BUY 98003 min ago

@ $9.92

Issued: 14 Feb 2024 @ 15:58


Return: -30.85%


Previous signal: Feb 13 - 13:33


Previous signal: Sell


Return: 2.06 %

Live Chart Being Loaded With Signals

Commentary (22 Apr 2024 @ 16:00):

AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments...

Stats
Today's Volume 176 846
Average Volume 396 662
Market Cap 296.39M
EPS $0 ( 2024-03-05 )
Next earnings date ( $-0.100 ) 2024-05-02
Last Dividend $1.000 ( 2010-01-27 )
Next Dividend $0 ( N/A )
P/E -13.45
ATR14 $0.0170 (0.25%)
Insider Trading
Date Person Action Amount type
2024-03-16 Zaderej Karen L. Buy 84 847 Common Stock
2024-03-16 Zaderej Karen L. Buy 12 975 Common Stock
2024-03-21 Zaderej Karen L. Sell 3 166 Common Stock
2024-03-16 Zaderej Karen L. Buy 12 500 Common Stock
2024-03-21 Zaderej Karen L. Sell 3 086 Common Stock
INSIDER POWER
41.86
Last 98 transactions
Buy: 1 200 055 | Sell: 468 598

Volume Correlation

Long: 0.18 (neutral)
Short: 0.80 (moderate)
Signal:(66.624) Neutral

AxoGen Inc Correlation

10 Most Positive Correlations
EA0.869
SFET0.857
CNET0.853
SMIT0.852
AHPI0.848
LLNW0.846
STAB0.845
GHVI0.839
RTPY0.838
AUID0.834
10 Most Negative Correlations
SHYF-0.915
RGLD-0.91
UBFO-0.902
MTRX-0.899
ICUI-0.897
TKNO-0.893
IPKW-0.892
STRA-0.891
VRTS-0.891
SGII-0.889

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

AxoGen Inc Correlation - Currency/Commodity

The country flag 0.83
( strong )
The country flag 0.65
( moderate )
The country flag 0.00
( neutral )
The country flag 0.41
( neutral )
The country flag 0.00
( neutral )
The country flag -0.65
( moderate negative )

AxoGen Inc Financials

Annual 2023
Revenue: $159.01M
Gross Profit: $127.87M (80.42 %)
EPS: $-0.510
Q4 2023
Revenue: $42.92M
Gross Profit: $33.76M (78.66 %)
EPS: $-0.0904
Q3 2023
Revenue: $41.27M
Gross Profit: $33.23M (80.51 %)
EPS: $-0.0950
Q2 2023
Revenue: $38.16M
Gross Profit: $30.93M (81.06 %)
EPS: $-0.160

Financial Reports:

No articles found.

AxoGen Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

AxoGen Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 1.724 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.0417 1992-07-10
Last Dividend $1.000 2010-01-27
Next Dividend $0 N/A
Payout Date 2010-02-12
Next Payout Date N/A
# dividends 3 --
Total Paid Out $1.102 --
Avg. Dividend % Per Year 0.00% --
Score 0.23 --
Div. Sustainability Score 1.724
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
(2029-03-28)
$0 Estimate 0.00 %
Dividend Stability
0.00 Very Bad
Dividend Score
0.23
Pay Frequency
Sporadic
Yearly Payout
Year Amount Yield
1992 $0.0417 0.45%
1993 $0 0.00%
1994 $0 0.00%
1995 $0 0.00%
1996 $0 0.00%
1997 $0 0.00%
1998 $0 0.00%
1999 $0 0.00%
2000 $0 0.00%
2001 $0 0.00%
2002 $0 0.00%
2003 $0 0.00%
2004 $0 0.00%
2005 $0.0600 4.00%
2006 $0 0.00%
2007 $0 0.00%
2008 $0 0.00%
2009 $0 0.00%
2010 $1.000 24.10%
2011 $0 0.00%
2012 $0 0.00%
2013 $0 0.00%
2014 $0 0.00%
2015 $0 0.00%
2016 $0 0.00%
2017 $0 0.00%
2018 $0 0.00%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-0.1341.500-2.69-4.03[0 - 0.5]
returnOnAssetsTTM-0.1081.200-3.62-4.34[0 - 0.3]
returnOnEquityTTM-0.2201.500-3.56-5.33[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM2.890.8000.5400.432[1 - 3]
quickRatioTTM2.040.8002.692.15[0.8 - 2.5]
cashRatioTTM1.2171.5004.356.53[0.2 - 2]
debtRatioTTM0.245-1.5005.92-8.88[0 - 0.6]
interestCoverageTTM-7.451.000-3.87-3.87[3 - 30]
operatingCashFlowPerShareTTM-0.1332.00-0.0443-0.0885[0 - 30]
freeCashFlowPerShareTTM-0.4792.00-0.240-0.479[0 - 20]
debtEquityRatioTTM0.503-1.5007.99-10.00[0 - 2.5]
grossProfitMarginTTM0.8041.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM-0.1351.000-4.70-4.70[0.1 - 0.6]
cashFlowToDebtRatioTTM-0.1191.000-1.771-1.771[0.2 - 2]
assetTurnoverTTM0.8080.8007.956.36[0.5 - 2]
Total Score1.724

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-15.121.000-1.6280[1 - 100]
returnOnEquityTTM-0.2202.50-2.29-5.33[0.1 - 1.5]
freeCashFlowPerShareTTM-0.4792.00-0.160-0.479[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-0.1332.00-0.0443-0.0885[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM-0.4441.500-6.290[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.03591.000-3.400[0.1 - 0.5]
Total Score-2.06

AxoGen Inc

AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, Germany, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators